ATE193205T1 - Lyophilisierte zusammensetzung, die s(+)-4,4'-(1- methyl-1,2-ethandiyl)-bis(2,6- piperazindion)enthält - Google Patents

Lyophilisierte zusammensetzung, die s(+)-4,4'-(1- methyl-1,2-ethandiyl)-bis(2,6- piperazindion)enthält

Info

Publication number: ATE193205T1
Authority: AT; Austria
Prior art keywords: icrf; piperazindione; ethanediyl; bis; methyl
Prior art date: 1991-10-25

Application number

AT92921457T

Other languages

English (en)

Inventor

Josephus Johannes Mar Holthuis

Alwinus Antonius Voetman

Original Assignee

Chiron Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-25

Filing date

1992-10-22

Publication date

2000-06-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10703550&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE193205(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-10-22 Application filed by Chiron Corp filed Critical Chiron Corp

2000-06-15 Application granted granted Critical

2000-06-15 Publication of ATE193205T1 publication Critical patent/ATE193205T1/de

Links

CYJAWBVQRMVFEO-UHFFFAOYSA-N piperazine-2,6-dione Chemical compound O=C1CNCC(=O)N1 CYJAWBVQRMVFEO-UHFFFAOYSA-N 0.000 title 1
BMKDZUISNHGIBY-ZETCQYMHSA-N (+)-dexrazoxane Chemical compound C([C@H](C)N1CC(=O)NC(=O)C1)N1CC(=O)NC(=O)C1 BMKDZUISNHGIBY-ZETCQYMHSA-N 0.000 abstract 3
238000001035 drying Methods 0.000 abstract 2
239000002253 acid Substances 0.000 abstract 1
230000002939 deleterious effect Effects 0.000 abstract 1
238000012792 lyophilization process Methods 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
- C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Peptides Or Proteins (AREA)

AT92921457T 1991-10-25 1992-10-22 Lyophilisierte zusammensetzung, die s(+)-4,4'-(1- methyl-1,2-ethandiyl)-bis(2,6- piperazindion)enthält ATE193205T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB919122720A GB9122720D0 (en)	1991-10-25	1991-10-25	(s)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)formulations and their preparation
PCT/EP1992/002400 WO1993007873A1 (en)	1991-10-25	1992-10-22	Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)

Publications (1)

Publication Number	Publication Date
ATE193205T1 true ATE193205T1 (de)	2000-06-15

Family

ID=10703550

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92921457T ATE193205T1 (de)	1991-10-25	1992-10-22	Lyophilisierte zusammensetzung, die s(+)-4,4'-(1- methyl-1,2-ethandiyl)-bis(2,6- piperazindion)enthält

Country Status (11)

Country	Link
EP (1)	EP0619735B1 (de)
AT (1)	ATE193205T1 (de)
AU (1)	AU2791292A (de)
DE (1)	DE69231098T2 (de)
DK (1)	DK0619735T3 (de)
ES (1)	ES2145748T3 (de)
GB (1)	GB9122720D0 (de)
GR (1)	GR3034135T3 (de)
MX (1)	MX9206139A (de)
PT (1)	PT101007B (de)
WO (1)	WO1993007873A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6265385B1 (en) *	1996-01-11	2001-07-24	Topo Target Aps	Topoisomerase II poison and bis-dioxopiperazine derivative combination therapy
BR0009473A (pt) *	1999-03-12	2001-11-27	Antianthra Aps	Tratamento de extravasamento acidental deantraciclinas
WO2007062076A2 (en) *	2005-11-23	2007-05-31	Novartis Ag	Dexrazoxane formulations and methods
CN114306251B (zh) *	2021-12-22	2023-08-11	乐普药业股份有限公司	一种含有右雷佐生的冻干制剂及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1234935A (en) *	1967-07-03	1971-06-09	Nat Res Dev	Piperazine derivatives
US4963551A (en) *	1987-12-21	1990-10-16	Erbamont Inc.	Stable lyophilized form of (S)-(+)-bis-4,4'-(1-methyl-1,2-ethanediyl)2,6-piperazinedione and solutions thereof

1991
- 1991-10-25 GB GB919122720A patent/GB9122720D0/en active Pending
1992
- 1992-10-22 ES ES92921457T patent/ES2145748T3/es not_active Expired - Lifetime
- 1992-10-22 AT AT92921457T patent/ATE193205T1/de active
- 1992-10-22 AU AU27912/92A patent/AU2791292A/en not_active Abandoned
- 1992-10-22 DE DE69231098T patent/DE69231098T2/de not_active Expired - Lifetime
- 1992-10-22 DK DK92921457T patent/DK0619735T3/da active
- 1992-10-22 EP EP92921457A patent/EP0619735B1/de not_active Expired - Lifetime
- 1992-10-22 WO PCT/EP1992/002400 patent/WO1993007873A1/en not_active Ceased
- 1992-10-23 MX MX9206139A patent/MX9206139A/es unknown
- 1992-10-23 PT PT101007A patent/PT101007B/pt not_active IP Right Cessation
2000
- 2000-08-07 GR GR20000401830T patent/GR3034135T3/el unknown

Also Published As

Publication number	Publication date
EP0619735B1 (de)	2000-05-24
GB9122720D0 (en)	1991-12-11
DE69231098D1 (de)	2000-06-29
DK0619735T3 (da)	2000-12-04
DE69231098T2 (de)	2000-09-14
PT101007A (pt)	1994-01-31
WO1993007873A1 (en)	1993-04-29
ES2145748T3 (es)	2000-07-16
AU2791292A (en)	1993-05-21
EP0619735A1 (de)	1994-10-19
PT101007B (pt)	1999-07-30
MX9206139A (es)	1993-07-01
GR3034135T3 (en)	2000-11-30

Similar Documents

Publication	Publication Date	Title
Du Vigneaud et al.	1954	The synthesis of oxytocin1
EP0207956B1 (de)	1990-07-04	Hirudin-pa und dessen derivate, verfahren zu deren herstellung und deren verwendung
JPS5495715A (en)	1979-07-28	Antithrombin agent and its preparation
AU2118488A (en)	1989-02-23	Improvements in or relating to methods of treating damaged skin
KR950703987A (ko)	1995-11-17	G-csf의 안정한 동결건조된 약제학적 제제(stable lyophilized pharma ceutical preparations g-csf)
DE58901401D1 (de)	1992-06-17	Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
ATE5125T1 (de)	1983-11-15	Pharmazeutische zusammensetzung, die sanguinaria und galangal enthaelt, zur behandlung von periodontitis und tumoren.
GR3019315T3 (en)	1996-06-30	Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
ATE6251T1 (de)	1984-03-15	Acylpeptide und pharmazeutische praeparate davon, sowie deren herstellung und verwendung.
SE8201784L (sv)	1983-01-15	Lekemedel for behandling av sockersjuka
GR3006172T3 (de)	1993-06-21
ATE148165T1 (de)	1997-02-15	Stabilisierung von hochgereinigten proteinen
JPS54147916A (en)	1979-11-19	Preparation of urokinase injection
FI101597B1 (fi)	1998-07-31	Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
DE69231098D1 (de)	2000-06-29	Lyophilisierte zusammensetzung, die s(+)-4,4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion)enthält
ATE356209T1 (de)	2007-03-15	Mutanten des thyroid-stimulierenden hormons
AU536582B2 (en)	1984-05-10	Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
KR840002657A (ko)	1984-07-16	인터페론 조성물의 제조방법
JPS6416799A (en)	1989-01-20	H-pth (1-34) composition and its preparation
NO883520L (no)	1989-02-13	Fremgangsmaate for fremstilling av et injeksjonspreparat.
DE1792196A1 (de)	1972-05-18	Verfahren zur Stabilisierung eines Proteins
ATE2746T1 (de)	1983-03-15	Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE135364T1 (de)	1996-03-15	Wasserfreie kristalle von 4-carbamoyl-1-beta-d- ribofuranosyl-imidazolium-5-olat
Harding	1963	The amino acid composition of human collagens from adult dura mater and post-menopausal uterus
NO894083L (no)	1989-10-12	Farmasoeytiske blandinger for behandling av adrenoleukodystrophy.

Legal Events

Date	Code	Title	Description
2000-09-15	UEP	Publication of translation of european patent specification